Crelosidenib gentisate
Crelosidenib (gentisate) is a potent, selective and orally active mutant isocitrate dehydrogenase (IDH) inhibitor with IC50 of 6.27 nM, 3.71 nM, 36.9 nM and 11.5 nM for IDH1 R132H, IDH1 R132C, IDH2 R140Q and IDH2 R172K mutant enzymes, respectively. Crelosidenib (gentisate) is less active at inhibiting the IDH wild-type enzymes.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2759438-85-0
- Formule: C42H48N6O11
- Masse moléculaire:812.86
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
IDH1 |
IDH2 |
Chemical Information
-
CAS No. 2759438-85-0
-
Masse moléculaire 812.86
-
Formule C42H48N6O11
-
SMILES
OC(C1=C(C=CC(O)=C1)O)=O.O=C2OCC3=CN=C(N=C3N2CC)N[C@@H](C)C(C=C4)=CC=C4[C@@H](N5CCN(CC5)C(C=C)=O)CC6CC6.OC(C7=C(C=CC(O)=C7)O)=O
-
Synonyms
LY3410738 gentisate; Mutant IDH1-IN-6 gentisate
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)